Boc-L-Homocitrulline

Boc-L-Homocitrulline is a protected, L-configured amino acid building block bearing a Boc-protecting group on the amino functionality and a side chain derived from the homocitrulline motif, which is frequently used to introduce urea/guanidinium-like functionality in peptide and peptidomimetic frameworks. This reagent form is designed for controlled incorporation during synthetic assembly, where the protected backbone and side-chain reactivity can be managed to support stepwise construction of complex amide and guanidine-containing targets. Researchers commonly select this Boc-protected variant to enable reliable segment coupling and downstream deprotection/reveal strategies in peptide chemistry and pharmaceutical intermediate development.

1. Peptide Building Block Use

Boc-L-Homocitrulline is used as a protected amino acid building block for constructing peptides and peptidomimetics that require a homocitrulline-derived side chain, including sequences where urea/guanidinium-like character is important for hydrogen bonding and electrostatic interactions. Peptide synthesis teams in custom peptide manufacturing and academic peptide chemistry groups rely on this Boc-protected form to support stepwise coupling workflows while keeping the amino functionality masked during chain assembly. The resulting protected intermediate strategy helps maintain synthetic control over reactive sites, which is particularly valuable when assembling longer or more functionalized peptide segments that incorporate basic side-chain motifs.

2. Pharmaceutical Intermediate Development

Boc-L-Homocitrulline is also applied as a pharmaceutical intermediate building block for preparing guanidine/urea-containing motifs used in medicinal chemistry programs and structure-activity relationship (SAR) studies. Process development and medicinal chemistry groups often choose Boc-protected amino acid reagents to manage chemoselectivity during the conversion of amino acid side-chain functionality into more elaborated heterocycle or amidine/urea-like pharmacophore elements. In this context, the protected amino group supports scalable synthetic sequences where selective functional group transformations are required before final deprotection or late-stage coupling steps.

3. Peptidomimetic Library Synthesis

Boc-L-Homocitrulline is frequently incorporated into peptidomimetic libraries designed to probe binding interactions driven by strongly polar, basic side-chain chemistry. Chemical biology and medicinal chemistry teams use Boc-protected amino acid derivatives to standardize building-block handling across parallel synthesis workflows, enabling consistent introduction of the homocitrulline-derived functionality into diverse analog series. This reagent format supports library generation where controlled protection of the amino group improves reproducibility during iterative coupling, purification, and subsequent functional group unveiling steps that produce the final analogs for downstream screening or biochemical characterization.

4. Protected Amino Acid Segment Coupling

Boc-L-Homocitrulline is well suited for segment condensation and protected-amino-acid assembly approaches where the Boc group provides a stable, orthogonal-compatible protecting strategy for managing reactivity during peptide fragment construction. Solid-phase peptide synthesis and solution-phase synthesis teams use this type of protected amino acid to introduce homocitrulline-derived side-chain features without prematurely exposing the amino functionality that could interfere with coupling efficiency or purification. By using Boc-L-homocitrulline as a defined synthetic unit, researchers can better control which functional groups are available at each stage, improving the reliability of multi-step synthesis of functionalized peptide intermediates and final targets.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Emu oil in combination with other active ingredients for treating skin imperfections

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate